To understand the mechanisms involved in the colitis and CAC vulnerability of Golm1−/− mice, we differentiated the contributions of hematopoietic cells from those of non-hematopoietic cells in colitis progression in Golm1−/−mice with bone marrow chimera transplantation (Supplementary Fig. 3a). This evidence concerns the gene GOLM1 and colitis.